Govt of India approves Covaxin production in Ankleshwar, Gujarat

New Delhi: The Government of India has approved vaccine manufacturing facility for production of Bharat Biotech’s Covaxin in Ankleshwar, Gujarat, said Union Health Minister Shri Mansukh Mandaviya today in a tweet.

Bharat Biotech had earlier announced the quick ramp up of additional manufacturing capacities for Covaxin at Chiron Behring vaccines, Ankleshwar, Gujarat, a wholly owned subsidiary of Bharat Biotech, starting from quarter four of year 2021.

Chiron Behring Vaccines Pvt, Ltd, a 100 per cent subsidiary of Bharat Biotech International Ltd was formed as a result of the purchase of the vaccines business of Hoechst AG by Chiron Corporation USA. It is one of the largest manufacturers of high-quality rabies vaccines in the world. Chiron Behring Vaccines is a WHO pre-qualified manufacturer of rabies vaccines, eligible for supplies to UN agencies and has product registration in more than 20 countries. Acquiring of Chiron Behring Vaccines Pvt Ltd has established Bharat Biotech as a global leader in rabies vaccines manufacturer. DeshGujarat

Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat.

Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world’s largest vaccine drive.

— Mansukh Mandaviya (@mansukhmandviya) August 10, 2021